Cargando…
Indiplon in the management of insomnia
Indiplon is a novel pyrazolopyrimidine, nonbenzodiazepine γ-aminobutyric acid (GABA) agonist studied for the treatment of insomnia. This article reviews the chemistry, pharmacology, clinical pharmacokinetics, drug interactions, clinical trials, safety, tolerability, contraindications, use in special...
Autores principales: | Lemon, Michael D, Strain, Joe D, Hegg, Annie M, Farver, Debra K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769245/ https://www.ncbi.nlm.nih.gov/pubmed/19920929 |
Ejemplares similares
-
Indiplon in the treatment of sleep disorders
por: Lankford, Alan
Publicado: (2007) -
Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?
por: Clem, James R, et al.
Publicado: (2009) -
A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy
por: Strain, Joe D, et al.
Publicado: (2010) -
New advances in the treatment of Clostridium difficile infection (CDI)
por: Hedge, Dennis D, et al.
Publicado: (2008) -
Advances in the management of insomnia
por: Pigeon, Wilfred R., et al.
Publicado: (2014)